Changzhou Qianhong Biopharma Co Ltd (002550) — Cash Flow-to-Debt Ratio
Changzhou Qianhong Biopharma Co Ltd (002550) has a Cash Flow-to-Debt Ratio of 0.61x as of September 2025, meaning its operating cash flow of CN¥156.34 Million could theoretically repay 1% of its total liabilities (CN¥255.86 Million) in one year. See how much free cash does Changzhou Qianhong Biopharma Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Changzhou Qianhong Biopharma Co Ltd Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for Changzhou Qianhong Biopharma Co Ltd across 19 annual periods. Also explore 002550 net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Changzhou Qianhong Biopharma Co Ltd (2007–2025)
Year-by-year debt coverage analysis for Changzhou Qianhong Biopharma Co Ltd. For market capitalisation and broader financial context, see market cap of Changzhou Qianhong Biopharma Co Ltd.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 1.13x | CN¥361.36 Million | CN¥320.64 Million | ▼ -31.3% |
| 2024 | 1.64x | CN¥514.71 Million | CN¥313.87 Million | ▼ -10.2% |
| 2023 | 1.83x | CN¥533.33 Million | CN¥292.17 Million | ▲ +1051.4% |
| 2022 | -0.19x | CN¥-71.47 Million | CN¥372.53 Million | ▼ -172.3% |
| 2021 | 0.27x | CN¥103.56 Million | CN¥390.24 Million | ▼ -67.7% |
| 2020 | 0.82x | CN¥317.28 Million | CN¥386.35 Million | ▲ +205.8% |
| 2019 | 0.27x | CN¥161.55 Million | CN¥601.65 Million | ▲ +575.5% |
| 2018 | 0.04x | CN¥25.45 Million | CN¥640.11 Million | ▼ -73.4% |
| 2017 | 0.15x | CN¥88.52 Million | CN¥591.41 Million | ▼ -58.7% |
| 2016 | 0.36x | CN¥221.01 Million | CN¥609.33 Million | ▼ -31.8% |
| 2015 | 0.53x | CN¥286.50 Million | CN¥538.67 Million | ▼ -62.4% |
| 2014 | 1.42x | CN¥252.01 Million | CN¥178.06 Million | ▼ -15.5% |
| 2013 | 1.68x | CN¥160.47 Million | CN¥95.77 Million | ▼ -50.9% |
| 2012 | 3.41x | CN¥199.82 Million | CN¥58.54 Million | ▲ +102.4% |
| 2011 | 1.69x | CN¥146.82 Million | CN¥87.07 Million | ▲ +32.5% |
| 2010 | 1.27x | CN¥171.51 Million | CN¥134.75 Million | ▲ +4323.2% |
| 2009 | 0.03x | CN¥8.35 Million | CN¥290.19 Million | ▼ -90.8% |
| 2008 | 0.31x | CN¥54.36 Million | CN¥173.75 Million | ▼ -33.1% |
| 2007 | 0.47x | CN¥35.99 Million | CN¥76.95 Million | — |